Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.36
+0.01 (0.07%)
Apr 24, 2026, 2:39 PM EDT - Market open

Enanta Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Cap
3882562202351,0781,150
Market Cap Growth
307.67%16.59%-6.66%-78.19%-6.20%25.09%
Enterprise Value
335.79121.925.33-113.44851.57906.85
Last Close Price
13.3611.9710.3611.1751.8756.81
PE Ratio
--3.12-1.89-1.75-8.78-14.49
PS Ratio
5.743.923.252.9712.5211.84
PB Ratio
3.063.961.701.093.362.88
P/TBV Ratio
2.453.951.701.083.332.87
P/FCF Ratio
--7.96-2.27-2.10-12.41-16.25
P/OCF Ratio
--13.28-2.79-2.28-12.72-16.43
EV/Sales Ratio
5.011.870.37-1.439.889.34
EV/EBITDA Ratio
--1.51-0.210.84-7.05-8.54
EV/EBIT Ratio
--1.43-0.210.83-6.88-8.28
EV/FCF Ratio
--3.79-0.261.01-9.80-12.82
Debt / Equity Ratio
0.420.850.420.100.070.00
Debt / EBITDA Ratio
-0.84-0.72-0.46-0.20-0.21-0.05
Debt / FCF Ratio
-3.09-1.80-0.57-0.24-0.29-0.07
Net Debt / Equity Ratio
-1.02-2.02-1.50-1.58-0.70-0.60
Net Debt / EBITDA Ratio
1.891.621.622.551.852.25
Net Debt / FCF Ratio
6.984.071.993.062.583.37
Asset Turnover
0.200.200.160.190.210.21
Quick Ratio
4.344.034.436.039.047.40
Current Ratio
4.444.215.206.7310.458.82
Return on Equity (ROE)
-60.01%-84.63%-67.17%-49.74%-33.78%-18.48%
Return on Assets (ROA)
-21.19%-25.47%-28.60%-33.46%-30.31%-17.40%
Return on Invested Capital (ROIC)
-57.27%-91.08%-135.90%-165.70%-94.18%-66.38%
Return on Capital Employed (ROCE)
-25.00%-30.99%-33.89%-36.83%-33.10%-25.35%
Earnings Yield
-18.60%-32.08%-52.90%-57.12%-11.39%-6.90%
FCF Yield
-4.80%-12.57%-44.05%-47.70%-8.06%-6.15%
Buyback Yield / Dilution
-9.53%-0.85%-0.90%-1.78%-2.14%-1.16%
Total Shareholder Return
-9.53%-0.85%-0.90%-1.78%-2.14%-1.16%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q